Circulating Tumor DNA Is Capable of Monitoring the Therapeutic Response and Resistance in Advanced Colorectal Cancer Patients Undergoing Combined Target and Chemotherapy

Colorectal cancer (CRC) is a highly lethal disease worldwide. The majority of patients receiving targeted therapy or chemotherapy develop drug resistance, while its molecular mechanism remains to be elucidated. The plasma circulating tumor DNA (ctDNA) exhibited the potential in identifying gene vari...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Hua, Liu, Xinyi, Chen, Yixin, Yang, Pan, Huang, Tanxiao, Song, Lele, Xu, Ruilian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154135/
https://www.ncbi.nlm.nih.gov/pubmed/32318348
http://dx.doi.org/10.3389/fonc.2020.00466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154135/
https://www.ncbi.nlm.nih.gov/pubmed/32318348
http://dx.doi.org/10.3389/fonc.2020.00466

Ejemplares similares